Falls Risk, Circadian Rhythms and Melatonin: Current Perspectives

References

• European Stakeholders Alliance for Active Ageing through Falls Prevention. Active ageing through preventing falls: “Falls prevention is everyone’s business”. Published 2015 Available from: http://www.eunaapa.org/wp-content/uploads/2015/09/Joint-Declaration_Sept-2015.pdf. Accessed 9, 2020.
   Google Scholar
• World Health Organisation. WHO global report on falls prevention in older age. Published 2007 Accessed 9, 2020.
   Google Scholar
• Bousquet J, Bewick M, Cano A, et al. Building bridges for innovation in ageing: synergies between action groups of the EIP on AHA. J Nutr Health Aging. 2017;21(1):92–104. doi:10.1007/s12603-016-0803-127999855
   PubMed Web of Science ®Google Scholar
• Blain H, Masud T, Dargent-Molina P, et al. A comprehensive fracture prevention strategy in older adults: the European Union geriatric medicine society (EUGMS) statement. J Nutr Health Aging. 2016;20(6):647–652. doi:10.1007/s12603-016-0741-y27273355
   PubMed Web of Science ®Google Scholar
• Goswami N. Falls and fall-prevention in older persons: geriatrics meets spaceflight! Front Physiol. 2017;8:1–9. doi:10.3389/fphys.2017.0060328154536
   PubMed Web of Science ®Google Scholar
• Goswami N, Blaber AP, Hinghofer-Szalkay H, Montani JP. Orthostatic intolerance in older persons: etiology and countermeasures. Front Physiol. 2017;8. doi:10.3389/fphys.2017.00803
   Web of Science ®Google Scholar
• World Health Organisation. Falls. Published 2018 Available from: https://www.who.int/news-room/fact-sheets/detail/falls. Accessed 9, 2020.
   Google Scholar
• Saraiva D. Quedas-indicador de qualidade assistencial. Nursing. 2008;19(235):28–35.
   Google Scholar
• Montero-Odasso M, Speechley M. Falls in cognitively impaired older adults: implications for risk assessment and prevention. J Am Geriatr Soc. 2018;66(2):367–375. doi:10.1111/jgs.1521929318592
   PubMed Web of Science ®Google Scholar
• Terroba‐Chambi C, Bruno V, Millar Vernetti P, Bruce D, Brockman S, Merello M. Design and validation of a new instrument to assess fear of falling in Parkinson’s disease. Mov Disorders. 2019;34:1496–1504. doi:10.1002/mds.27820
   Web of Science ®Google Scholar
• Cornelissen G, Otsuka K. Chronobiology of aging: a mini-review. Gerontology. 2017;63(2):118–128. doi:10.1159/00045094527771728
   PubMed Web of Science ®Google Scholar
• Ju YE, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587–593. doi:10.1001/jamaneurol.2013.233423479184
   PubMed Web of Science ®Google Scholar
• Baron KG, Reid KJ. Circadian misalignment and health. Int Rev Psychiatry. 2014;26(2):139–154. doi:10.3109/09540261.2014.91114924892891
   PubMed Web of Science ®Google Scholar
• Tranah GJ, Blackwell T, Stone KL, et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol. 2011;70(5):722–732. doi:10.1002/ana.2246822162057
   PubMed Web of Science ®Google Scholar
• da Silva VP, Ramalho Oliveira BR, Tavares Mello RG, Moraes H, Deslandes AC, Laks J. Heart rate variability indexes in dementia: a systematic review with a quantitative analysis. Curr Alzheimer Res. 2018;15(1):80–88.28558638
   PubMed Web of Science ®Google Scholar
• Toledo MA, Junqueira LF. Cardiac autonomic modulation and cognitive status in Alzheimer’s disease. Clin Auton Res. 2010;20(1):11–17. doi:10.1007/s10286-009-0035-019830511
   PubMed Web of Science ®Google Scholar
• Holth J, Patel T, Holtzman DM. Sleep in Alzheimer’s disease – beyond amyloid. Neurobiol Sleep Circadian Rhythms. 2017;2:4–14. doi:10.1016/j.nbscr.2016.08.00228217760
   PubMedGoogle Scholar
• Vaz Fragoso CA, Gahbauer EA, Van Ness PH, Gill TM. Sleep-wake disturbances and frailty in community-living older persons. J Am Geriatr Soc. 2009;57(11):2094–2100. doi:10.1111/j.1532-5415.2009.02522.x19793356
   PubMed Web of Science ®Google Scholar
• Terroba-Chambi C, Bruno V, Vigo D, Merello M. Heart rate variability and falls in Huntington’s disease. Clin Auton Res. 2020. doi:10.1007/s10286-020-00669-2
   Web of Science ®Google Scholar
• López-Soto PJ, Manfredini R, Smolensky MH, Rodríguez-Borrego MA. 24-hour pattern of falls in hospitalized and long-term care institutionalized elderly persons: a systematic review of the published literature. Chronobiol Int. 2015;32(4):548–556. doi:10.3109/07420528.2014.98729525471448
   PubMed Web of Science ®Google Scholar
• Lee Gierke C, Cornelissen G. Chronomics analysis toolkit (CATkit). Biol Rhythm Res. 2016;47(2):163–181. doi:10.1080/09291016.2015.1094965
   Web of Science ®Google Scholar
• Gubin DG, Malishevskaya ТN, Astakhov YS, et al. Progressive retinal ganglion cell loss in primary open-angle glaucoma is associated with temperature circadian rhythm phase delay and compromised sleep. Chronobiol Int. 2019;36(4):564–577. doi:10.1080/07420528.2019.156674130663431
   PubMed Web of Science ®Google Scholar
• Cornélissen G. Altered circadian energy metabolism and chronobiological risk factors of chronic diseases In: The Role of Functional Food Security in Global Health. Academic Press; 2019:513–524.
   Google Scholar
• Cornélissen G, Halberg F, Bakken EE, et al. Chronobiology of high blood pressure. Scr Med (Brno). 2007;80(4):157–166.19122770
   PubMedGoogle Scholar
• Halberg F, Powell D, Otsuka K, et al. Diagnosing vascular variability anomalies (VVAs), not only MESOR-hypertension (MH). Am J Physiol Heart Circ Physiol. 2013;305:H279–H294. doi:10.1152/ajpheart.00212.201323709604
   PubMed Web of Science ®Google Scholar
• Shinagawa M, Kubo Y, Otsuka K, Ohkawa S, Cornélissen G, Halberg F. Impact of circadian amplitude and chronotherapy: relevance to prevention and treatment of stroke. Biomed Pharmacother. 2001;55(Suppl 1):125s–132s. doi:10.1016/S0753-3322(01)90017-411774859
   PubMed Web of Science ®Google Scholar
• Cornélissen G, Rigatuso J, Wang ZR, et al. Case report of an acceptable average but overswinging blood pressure in circadian hyper-amplitude-tension, CHAT. Neuro Endocrinol Lett. 2003;24:84–91.
   Web of Science ®Google Scholar
• Goswami N, Rössler A, Lackner HK, Schneditz D, Grasser E, Hinghofer-Szalkay H. Heart rate and stroke volume response patterns to augmented orthostatic stress. Clin Auton Res. 2009;19:157–165. doi:10.1007/s10286-009-0001-x19271261
   PubMed Web of Science ®Google Scholar
• Lackner HK, Goswami N, Papousek I, Jezova D, Hinghofer-Szalkay H, Montani JP. Time course of cardiovascular responses induced by mental and orthostatic challenges. Int J Psychophysiol. 2010;75:48–53. doi:10.1016/j.ijpsycho.2009.11.00319951722
   PubMed Web of Science ®Google Scholar
• Patel K, Rössler A, Lackner HK, et al. Effect of postural changes on cardiovascular parameters across gender. Medicine (Baltimore). 2016;95(28):e4149. doi:10.1097/MD.000000000000414927428203
   PubMed Web of Science ®Google Scholar
• Sachse C, Trozic I, Brix B, Roessler A, Goswami N. Sex differences in cardiovascular responses to orthostatic challenge in healthy older persons: a pilot study. Physiol Int. 2019;106(3):236–249. doi:10.1556/2060.106.2019.1631304761
   PubMed Web of Science ®Google Scholar
• Trozic I, Platzer D, Fazekas F, et al. Postural hemodynamic parameters in older persons have a seasonal dependency: a pilot study. Z Gerontol Geriatr. 2020;53:145–55.30868225
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Blaber AP, Kneihsl M, et al. Poststroke alterations in heart rate variability during orthostatic challenge. Medicine. 2017;96(14). doi:10.1097/MD.0000000000005989
   Web of Science ®Google Scholar
• Xu D, Tremblay MF, Verma AK, Tavakolian K, Goswami N, Blaber AP. Cardio-postural interactions and muscle-pump baroreflex are severely impacted by 60-day bedrest immobilization. Sci Rep. 2020;10(1):12042. doi:10.1038/s41598-020-68962-832694819
   PubMed Web of Science ®Google Scholar
• Zorko A, Frühwirth M, Goswami N, Moser M, Levnajić Z. Heart rhythm analyzed via shapelets distinguishes sleep from awake. Front Physiol. 2019;10:1554. doi:10.3389/fphys.2019.0155432009972
   PubMed Web of Science ®Google Scholar
• Otsuka K, Kubo Y, Yamanaka G, et al. Tokyo cognitive assessment for mild cognitive impairment, ToCA-MCI: validity and utility in elderly Japanese. Ther Res. 2017;38:579–621.
   Google Scholar
• Halberg CG. A maverick ahead of his time. Herald of the International Academy of Sciences. Russian Section. 2018;1:78–84.
   Google Scholar
• Herold M, Cornélissen G, Rawson M, et al. About-daily (Circadian) and about-weekly (Circaseptan) patterns of human salivary melatonin. J Anti Aging Med. 2000;3:263–267. doi:10.1089/rej.1.2000.3.263
   Google Scholar
• Tarquini B, Cornélissen G, Perfetto F, Tarquini R, Halberg F. Chronome assessment of circulating melatonin in humans. In Vivo (Brooklyn). 1997;11(6):473–484.
   Web of Science ®Google Scholar
• Wetterberg L, Halberg F, Halberg E, et al. Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks. Acta Med Scand. 1986;220(1):71–81. doi:10.1111/j.0954-6820.1986.tb02732.x3766210
   PubMedGoogle Scholar
• Tarquini B, Cornélissen G, Tarquini R, Perfetto F, Halberg F. General and unspecific damping by malignancy of the circadian amplitude of circulating human melatonin? Neuro Endocrinol Lett. 1999;20(1–2):25–28.11473228
   PubMedGoogle Scholar
• Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disturbances and risk of falls in older community-dwelling men: the outcomes of sleep disorders in older men (MrOS sleep) study. J Am Geriatr Soc. 2014;62(2):299–305. doi:10.1111/jgs.1264924428306
   PubMed Web of Science ®Google Scholar
• Cardinali DP. Melatonin as a chronobiotic/cytoprotector: its role in healthy aging. Biol Rhythm Res. 2019;50(1):28–45. doi:10.1080/09291016.2018.1491200
   Web of Science ®Google Scholar
• Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR. Melatonin and brain inflammaging. Prog Neurobiol. 2015;127–128:46–63. doi:10.1016/j.pneurobio.2015.02.001
   PubMed Web of Science ®Google Scholar
• Sharafati-Chaleshtori R, Shirzad H, Rafieian-Kopaei M, Soltani A. Melatonin and human mitochondrial diseases. J Res Med Sci. 2017;22:2. doi:10.4103/1735-1995.19909228400824
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ. Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules. 2015;20(10):18886–18906. doi:10.3390/molecules20101888626501252
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali D, Poeggeler B, Hardeland R. Melatonin: nature’s most versatile biological signal? FEBS J. 2006;273:2813–2838. doi:10.1111/j.1742-4658.2006.05322.x16817850
   PubMed Web of Science ®Google Scholar
• Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms. 1997;12(6):657–665. doi:10.1177/0748730497012006229406042
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Emens J, Jackman A, Yuhas K. Circadian uses of melatonin in humans. Chronobiol Int. 2006;23(1–2):403–412. doi:10.1080/0742052050054586216687313
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335–353. doi:10.1016/j.pneurobio.2008.04.00118571301
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Rosales-Corral S, Tan DX, Jou MJ, Galano A, Xu B. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell Mol Life Sci. 2017;74(21):3863–3881. doi:10.1007/s00018-017-2609-728864909
   PubMed Web of Science ®Google Scholar
• Cardinali DP. Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne). 2019;10:480.31379746
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev. 2010;62(3):343–380.20605968
   PubMed Web of Science ®Google Scholar
• Cecon E, Oishi A, Jockers R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br J Pharmacol. 2018;175(16):3263–3280. doi:10.1111/bph.1395028707298
   PubMed Web of Science ®Google Scholar
• Acuña-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014;71(16):2997–3025.24554058
   PubMed Web of Science ®Google Scholar
• Cardinali DP. Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection? 2019.
   Google Scholar
• Alpini D, Cesarani A, Fraschini F, Kohen-Raz R, Capobianco S, Cornelio F. Aging and vestibular system: specific tests and role of melatonin in cognitive involvement. Arch Gerontol Geriatr Suppl. 2004;9:13–25. doi:10.1016/j.archger.2004.04.00515207391
   PubMedGoogle Scholar
• Fraschini F, Cesarani A, Alpini D, Esposti D, Stankov BM. Melatonin influences human balance. Biol Signals Recept. 1999;8(1–2):111–119. doi:10.1159/00001457810085472
   PubMedGoogle Scholar
• Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J. 2015;14:102. doi:10.1186/s12937-015-0093-126424587
   PubMed Web of Science ®Google Scholar
• Coto-Montes A, Boga JA, Tan DX, Reiter RJ. Melatonin as a potential agent in the treatment of sarcopenia. Int J Mol Sci. 2016;17(10):1771. doi:10.3390/ijms17101771
   Web of Science ®Google Scholar
• Stacchiotti A, Favero G, Rodella LF. Impact of melatonin on skeletal muscle and exercise. Cells. 2020;9(2):288. doi:10.3390/cells9020288
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim JH, Lee DC. Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women. Menopause. 2014;21(1):39–44. doi:10.1097/GME.0b013e318291f6c823760432
   PubMed Web of Science ®Google Scholar
• Obayashi K, Saeki K, Maegawa T, et al. Melatonin secretion and muscle strength in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. J Gerontol a Biol Sci Med Sci. 2016;71(9):1235–1240. doi:10.1093/gerona/glw03026933161
   PubMed Web of Science ®Google Scholar
• Thrift AP, Xiao L, Patel SR, Tworoger SS, McTiernan A, Duggan C. Effects of physical activity on melatonin levels in previously sedentary men and women. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1696–1699. doi:10.1158/1055-9965.EPI-14-029924859868
   PubMed Web of Science ®Google Scholar
• Dardevet D, Rémond D, Peyron MA, Papet I, Savary-Auzeloux I, Mosoni L. Muscle wasting and resistance of muscle anabolism: the “anabolic threshold concept” for adapted nutritional strategies during sarcopenia. Sci World J. 2012;2012:269531. doi:10.1100/2012/269531
   Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Pedersen SB, Heickendorff L, Mosekilde L, Rejnmark L. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: a randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2016;84(3):342–347. doi:10.1111/cen.1294226352863
   PubMed Web of Science ®Google Scholar
• Li T, Jiang S, Lu C, et al. Melatonin: another avenue for treating osteoporosis? J Pineal Res. 2019;66(2):e12548. doi:10.1111/jpi.1254830597617
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res. 2015;59(2):221–229. doi:10.1111/jpi.1225226036434
   PubMed Web of Science ®Google Scholar
• Maria S, Swanson MH, Enderby LT, et al. Melatonin-micronutrients osteopenia treatment study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures. Aging (Albany NY). 2017;9(1):256–285.28130552
   PubMedGoogle Scholar
• Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10–22. doi:10.1016/j.smrv.2016.06.00528648359
   PubMed Web of Science ®Google Scholar
• Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. doi:10.1371/journal.pone.006377323691095
   PubMed Web of Science ®Google Scholar
• Li T, Jiang S, Han M, et al. Exogenous melatonin as a treatment for secondary sleep disorders: a systematic review and meta-analysis. Front Neuroendocrinol. 2019;52:22–28. doi:10.1016/j.yfrne.2018.06.00429908879
   PubMed Web of Science ®Google Scholar
• Wilson S, Anderson K, Baldwin D, et al. British association for psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol. 2019;33(8):923–947. doi:10.1177/026988111985534331271339
   PubMed Web of Science ®Google Scholar
• Palagini L, Manni R, Aguglia E, et al. Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies. Front Psychiatry. 2020;11:558. doi:10.3389/fpsyt.2020.0055832670104
   PubMed Web of Science ®Google Scholar
• Geoffroy PA, Micoulaud Franchi J-A, Lopez R, Schroder CM. The use of melatonin in adult psychiatric disorders: expert recommendations by the French institute of medical research on sleep (SFRMS). L’Encéphale. 2019;45(5):413–423. doi:10.1016/j.encep.2019.04.068
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Galano A. Melatonin: exceeding expectations. Physiology (Bethesda). 2014;29(5):325–333.25180262
   PubMed Web of Science ®Google Scholar
• Gerdin MJ, Masana MI, Rivera-Bermúdez MA, et al. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J. 2004;18(14):1646–1656. doi:10.1096/fj.03-1339com15522910
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA. Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int. 2002;19(3):649–658. doi:10.1081/CBI-12000454612069043
   PubMed Web of Science ®Google Scholar
• Rahbari-Oskoui FF, Abramson JL, Bruckman AM, et al. Nighttime administration of high-dose, sustained-release melatonin does not decrease nocturnal blood pressure in African-American patients: results from a preliminary randomized, crossover trial. Complement Ther Med. 2019;43:157–164. doi:10.1016/j.ctim.2019.01.02630935524
   PubMed Web of Science ®Google Scholar
• Moser M, Lehofer M, Sedminek A, et al. Heart rate variability as a prognostic tool in cardiology. A contribution to the problem from a theoretical point of view. Circulation. 1994;90:1078–1082. doi:10.1161/01.CIR.90.2.10788044922
   PubMed Web of Science ®Google Scholar
• Piepoli M, Sleight P, Leuzzi S, et al. Origin of respiratory sinus arrhythmia in conscious humans – an important role for arterial carotid baroreceptors. Circulation. 1997;95(7):1813–1821. doi:10.1161/01.CIR.95.7.18139107168
   PubMed Web of Science ®Google Scholar
• Moser M, Lehofer M, Hoehn-Saric R, et al. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J Affect Disord. 1998;48(2–3):115–124. doi:10.1016/S0165-0327(97)00164-X9543200
   PubMed Web of Science ®Google Scholar
• Zulfiqar U, Jurivich DA, Gao W, Singer DH. Relation of high heart rate variability to healthy longevity. Am J Cardiol. 2010;105(8):1181–1185. doi:10.1016/j.amjcard.2009.12.02220381674
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Yasue H, Moriyama Y, et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J. 2001;141(5):E9. doi:10.1067/mhj.2001.11436811320384
   PubMedGoogle Scholar
• Gubin DG, Gubin GD, Gapon LI, Weinert D. Daily melatonin administration attenuates age-dependent disturbances of cardiovascular rhythms. Curr Aging Sci. 2016;9(1):5–13. doi:10.2174/187460980966615113022001126632428
   PubMedGoogle Scholar